
In a controlled test of 12 AI models across 33 physician-written clinical cases, a clearly labeled pharmaceutical ad raised the share of responses choosing the advertised drug from 35% to 47.6%.
The Centers for Medicare and Medicaid Services has re-opened the window to file for exemptions to avoid the Medicare e-prescribing penalty in 2013.





